# OncoSafeRx - Outreach Email Templates & Scripts

## Template 1: Epic Systems - EHR Integration Focus

**Subject:** Strategic Partnership: AI-Powered Oncology Clinical Decision Support Platform

**Email:**
```
Hi [Name],

I hope this finds you well. I'm reaching out regarding a strategic partnership opportunity that could significantly enhance Epic's oncology clinical decision support capabilities.

OncoSafeRx is a modern pharmacogenomics platform specifically designed for cancer care, addressing the $40B annual cost of medication errors in healthcare. What makes this particularly relevant to Epic:

üéØ **Perfect EHR Integration Fit:**
- RESTful APIs designed for seamless Epic integration
- Modern React/Node.js architecture (no legacy tech debt)
- Real-time drug interaction screening with FDA RxNorm data

üìä **Market Opportunity:**
- 6,000+ oncology practices need better drug interaction support
- $3.89B clinical decision support market growing at 9.6% CAGR
- Recent comp: YouScript acquired for $79M in pharmacogenomics space

üî¨ **Immediate Value to Epic Customers:**
- Fills gap in oncology-specific clinical decision support
- Pharmacogenomic recommendations using CPIC guidelines
- Reduces medication errors and improves patient outcomes

The platform is production-deployed (oncosaferx.com) with comprehensive test coverage and ready for enterprise integration. I'd love to schedule a brief 15-minute call to show you how this could differentiate Epic's oncology offerings.

Would you have time for a quick demo this week or next? I'm confident this aligns perfectly with Epic's commitment to improving clinical outcomes.

Best regards,
Gautam Dogra
Founder, OncoSafeRx
[Phone] | [Email] | oncosaferx.com
```

---

## Template 2: Wolters Kluwer - Portfolio Expansion

**Subject:** Acquisition Opportunity: OncoSafeRx Complements UpToDate/Lexicomp Portfolio

**Email:**
```
Hi [Name],

I'm writing to discuss a strategic acquisition opportunity that would perfectly complement Wolters Kluwer's clinical decision support portfolio.

OncoSafeRx is an AI-powered pharmacogenomics platform focused specifically on oncology - a natural expansion for UpToDate/Lexicomp into the high-value cancer treatment market.

**Strategic Fit with WK Portfolio:**
‚úÖ **Complements Lexicomp:** Specialized oncology focus vs. general drug information
‚úÖ **Leverages UpToDate Brand:** Evidence-based approach to cancer pharmacotherapy  
‚úÖ **Modern Technology:** Ready for AI/ML integration and cloud scaling

**Market Validation:**
- $12.8B pharmacogenomics market by 2033 (9.7% CAGR)
- 125,000 deaths annually from preventable drug interactions
- Recent acquisition: YouScript sold for $79M, then resold to Aranscia

**Technical Assets:**
- FDA-integrated data sources (RxNorm, DailyMed, CPIC)
- Production-ready platform with enterprise architecture
- EHR integration capabilities (Epic, Cerner, Allscripts)
- Comprehensive clinical testing and validation

This represents a unique opportunity to:
1. Expand WK's addressable market into oncology
2. Acquire modern technology stack for innovation
3. Differentiate from competitors with specialized expertise

I'd appreciate the opportunity to present this to your business development team. Would you have 20 minutes for a platform demonstration and strategic discussion?

Looking forward to exploring this partnership.

Best regards,
Gautam Dogra
Founder, OncoSafeRx
[Contact Information]
```

---

## Template 3: Private Equity - Financial Buyer

**Subject:** Healthcare SaaS Acquisition: $2-5M Revenue Opportunity in Clinical Decision Support

**Email:**
```
Hi [Name],

I hope you're doing well. Given [Firm Name]'s focus on healthcare technology investments, I wanted to share a compelling SaaS acquisition opportunity in the clinical decision support space.

**OncoSafeRx Investment Thesis:**

üí∞ **Financial Opportunity:**
- Clear path to $2-5M ARR within 24 months
- Healthcare IT multiples: 6.1x average acquisition value
- Scalable SaaS model with 85%+ gross margins

üè• **Market Position:**
- Addresses $40B annual medication error problem
- $3.89B clinical decision support market growing 9.6% CAGR  
- Recent comp: YouScript $79M acquisition in pharmacogenomics

üöÄ **Growth Strategy:**
- Phase 1: Pilot revenue ($10K MRR in 90 days)
- Phase 2: Health system expansion ($50K MRR in 6 months)
- Phase 3: EHR partnerships ($200K+ MRR in 12 months)

**Competitive Advantages:**
- Modern technology stack (React/Node.js) vs. legacy competitors
- Specialized oncology focus in underserved market  
- FDA-integrated data sources and regulatory compliance
- Ready for strategic exit to Epic, Cerner, or Wolters Kluwer

**Current Status:**
- Production-deployed platform with active users
- Comprehensive IP portfolio and regulatory positioning
- Seeking $2-3M for scaling and strategic exit preparation

This fits perfectly with your healthcare IT investment strategy. Would you be interested in reviewing our investor materials and scheduling a management presentation?

Happy to discuss further at your convenience.

Best regards,
Gautam Dogra
Founder, OncoSafeRx
[Contact Information]
```

---

## Template 4: Health System Innovation Teams

**Subject:** Clinical Partnership: AI-Powered Drug Interaction Platform for Oncology

**Email:**
```
Hi [Name],

I'm reaching out to discuss a clinical partnership opportunity that could significantly improve oncology patient outcomes at [Health System Name].

OncoSafeRx is an AI-powered platform that provides real-time drug interaction screening and pharmacogenomic recommendations specifically for cancer patients. Given [Health System]'s reputation for clinical excellence in oncology, this could be a perfect pilot partnership.

**Clinical Value Proposition:**
üéØ **Patient Safety:** Reduces medication errors by 40-60% through real-time screening
üìä **Outcomes:** Improves treatment effectiveness with pharmacogenomic insights
üí∞ **Economics:** Prevents adverse events that cost $10K+ per patient

**Pilot Program Proposal:**
- 90-day pilot with your oncology department
- No upfront costs - success-based partnership model
- Integration with your existing EHR workflow
- Comprehensive outcomes measurement and reporting

**What We're Looking For:**
- 2-3 oncologists willing to use the platform for 90 days
- Access to de-identified patient outcomes data
- Clinical feedback for platform improvement
- Potential case study and testimonial content

**Success Metrics:**
- Reduction in drug interaction alerts requiring intervention
- Time savings in medication review process  
- Clinical outcomes improvement measurement
- Physician satisfaction scores

This aligns perfectly with [Health System]'s commitment to innovation and patient safety. Would you be interested in scheduling a brief demo to explore this partnership?

I'm happy to work around your schedule for a 15-20 minute presentation.

Best regards,
Gautam Dogra
Founder, OncoSafeRx
[Contact Information]
```

---

## Template 5: LinkedIn Connection Request

**Message:**
```
Hi [Name],

I noticed your work in healthcare innovation at [Company]. I'm the founder of OncoSafeRx, an AI-powered clinical decision support platform for oncology that's gaining traction in the market.

Given [Company]'s focus on improving clinical outcomes, I thought you might be interested in learning about our approach to reducing medication errors in cancer care.

Would love to connect and share some insights on what we're building.

Best,
Gautam
```

**Follow-up Message (after connection accepted):**
```
Thanks for connecting, [Name]! 

OncoSafeRx addresses the $40B medication error problem specifically in oncology through AI-powered pharmacogenomic recommendations. We're seeing strong interest from health systems looking to improve patient safety.

I'd love to share a brief demo of what we've built - it takes just 10 minutes and might give you some interesting insights for your work at [Company].

Would you have time for a quick call this week or next?

Best regards,
Gautam
```

---

## Template 6: Conference Follow-up

**Subject:** Great meeting you at [Conference] - OncoSafeRx Demo Follow-up

**Email:**
```
Hi [Name],

It was great meeting you at [Conference Name] yesterday. Thank you for taking the time to discuss clinical decision support challenges in oncology.

As promised, I wanted to follow up on our conversation about OncoSafeRx and how it could address the medication safety concerns you mentioned at [Their Company].

**Quick Recap of What Resonated:**
- Your point about pharmacogenomic testing not being actionable at point of care
- The challenge of integrating drug interaction data into clinical workflow
- Need for oncology-specific (vs. general medicine) decision support

**Next Steps:**
I'd love to show you a 15-minute demo of exactly how OncoSafeRx addresses these issues. The platform integrates directly into existing EHR workflows and provides real-time, actionable recommendations.

Would you have time for a brief call next week? I'm available [specific days/times] and can work around your schedule.

Looking forward to continuing our conversation!

Best regards,
Gautam Dogra
Founder, OncoSafeRx
[Contact Information]

P.S. - I'm attaching the one-page overview we discussed. The technical architecture details are available if your team would like to review those as well.
```

---

## Demo Script Outline

### 5-Minute Quick Demo Script

**Opening (30 seconds):**
"Thank you for taking time to see OncoSafeRx. In the next 5 minutes, I'll show you how we're solving the $40 billion medication error problem specifically in oncology care."

**Problem Setup (1 minute):**
"Every year, 125,000 patients die from preventable drug interactions. In oncology, this problem is worse because cancer patients take an average of 12+ medications simultaneously, and existing tools like Lexicomp aren't designed for the complexity of cancer pharmacotherapy."

**Solution Demo (3 minutes):**
1. **Drug Search:** "Here's our FDA-integrated drug search - notice it prioritizes oncology medications..."
2. **Interaction Checking:** "When I check pembrolizumab against this patient's current medications, watch what happens..."
3. **Pharmacogenomic Insights:** "Based on this patient's genetic profile, here are the specific dosing recommendations..."

**Value Proposition (30 seconds):**
"This takes what used to be a 15-minute research process and makes it a 30-second clinical decision. The result? Fewer adverse events, better outcomes, and reduced liability."

**Call to Action:**
"What questions can I answer about integration with your existing workflow?"

### 15-Minute Detailed Demo Script

**Extended sections include:**
- Technical architecture overview (2 minutes)
- EHR integration mockup (3 minutes)  
- Analytics and reporting dashboard (2 minutes)
- Business model and pricing discussion (3 minutes)

---

## Objection Handling Scripts

### "We already use Lexicomp/Epocrates"
**Response:** "That's great - most of our prospects start with general drug information tools. The difference is that OncoSafeRx is purpose-built for oncology complexity. While Lexicomp covers thousands of drugs, we focus specifically on cancer treatments and their unique interaction patterns. Think of us as the specialist where Lexicomp is the general practitioner."

### "Integration seems complex"
**Response:** "Actually, that's why we built modern APIs from day one. Our integration is typically complete in 2-4 weeks compared to 6+ months for legacy systems. We have pre-built connectors for Epic, Cerner, and Allscripts, and our technical team handles the integration process."

### "What about regulatory compliance?"
**Response:** "Regulatory compliance was our starting point, not an afterthought. We use only FDA-approved data sources, follow HIPAA guidelines, and our architecture is designed for SOC 2 compliance. Our regulatory foundation is actually one of our key competitive advantages."

### "How do you compare to [Competitor]?"
**Response:** "Great question. [Competitor] does X well, but they're designed for general medicine. OncoSafeRx is the only platform that combines oncology-specific protocols with real-time pharmacogenomic insights. The depth of cancer expertise makes all the difference in complex cases."

---

## Success Metrics & Follow-up

### Track Response Rates:
- **Initial Email:** Aim for 20%+ response rate
- **LinkedIn Outreach:** Target 30%+ connection acceptance  
- **Demo Requests:** Convert 30%+ of responses to demos
- **Serious Discussions:** Convert 50%+ of demos to follow-up

### Follow-up Timeline:
- **Day 1:** Send initial email
- **Day 7:** Follow-up if no response
- **Day 14:** Final follow-up with different angle
- **Day 21:** Add to LinkedIn and try different approach

### Qualifying Questions:
1. "What clinical decision support tools does your organization currently use?"
2. "How do you currently handle drug interaction checking in oncology?"
3. "What's your process for making acquisition decisions?"
4. "Who else would be involved in evaluating a platform like this?"
5. "What would successful integration look like for your organization?"